The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.
about
Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.Decision support systems for incurable non-small cell lung cancer: a systematic reviewComparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
P2860
The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The applicability of a predict ...... all-cell lung cancer patients.
@en
The applicability of a predict ...... all-cell lung cancer patients.
@nl
type
label
The applicability of a predict ...... all-cell lung cancer patients.
@en
The applicability of a predict ...... all-cell lung cancer patients.
@nl
prefLabel
The applicability of a predict ...... all-cell lung cancer patients.
@en
The applicability of a predict ...... all-cell lung cancer patients.
@nl
P2860
P50
P356
P1433
P1476
The applicability of a predict ...... mall-cell lung cancer patients
@en
P2093
Janusz Milanowski
P2860
P304
P356
10.1159/000322843
P50
P577
2011-01-18T00:00:00Z